Evaluation of adverse drug reactions in a tertiary care hospital in India
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20250485Keywords:
Adverse drug reactions, Pharmacovigilance, Anti-infective, Clinical pharmacist, CausalityAbstract
Background: Adverse drug reaction (ADR) is a major concern in the healthcare system and has been a persistent issue in the health sector. This study aimed to evaluate and assess the ADRs reported, the system organ class (SOC) affected, seriousness, outcomes, causality.
Methods: A retrospective observational study in a tertiary care hospital from April 2021 to May 2024. A descriptive analysis of reactions, causality of suspected drugs was carried out according to the setting analysed.
Results: Out of 7,396 individual case safety report (ICSR) reported, the highest number of ADRS was reported in the age group of 18-65 years (57.8%) and male patients (51.1%). Using World Health Organization-Uppsala Monitoring Centre (WHO-UMC) causality assessment scale, 67.1% events were possible. A significant majority of drug reported as ‘certain’ were of anti-infective class (51.03%). Most frequently affected SOC was blood and lymphatic system disorders (15.9%), Of all events, greater part of the reactions was non-serious (95.3%), the most drugs causing ADRs was anti neoplastic and immunodulating agents (40.4%) and 47.2% of drugs were high alert medications. The greater part of ADRs reporting was carried out by clinical pharmacists (95.9%).
Conclusions: The results highlighted the importance of clinical pharmacist in monitoring and spontaneous reporting of ADRs. Awareness and educational programs may help in active reporting among all healthcare providers.
Metrics
References
Venkatasubbaiah M, Dwarakanadha Reddy P, Satyanarayana SV. Analysis and reporting of adverse drug reactions at a tertiary care teaching hospital. Alex J Med. 2018;54(4):597-603. DOI: https://doi.org/10.1016/j.ajme.2018.10.005
Sendekie AK, Netere AK, Tesfaye S, Dagnew EM, Belachew EA. Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital: A prospective observational follow-up study. PLoS One. 2023;18(2):e0282096. DOI: https://doi.org/10.1371/journal.pone.0282096
Giardina C, Cutroneo PM, Mocciaro E, Russo GT, Mandraffino G, Basile G, et al. Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study. Front Pharmacol. 2018;9:350. DOI: https://doi.org/10.3389/fphar.2018.00350
Asiamah M, Akuffo KO, Nortey P, Donkor N, Danso-Appiah A. Spontaneous reporting of adverse drug reaction among health professionals in Ghana. Arch Public Health. 2022;80(1):33. DOI: https://doi.org/10.1186/s13690-021-00783-1
Sultana J, Cutroneo P, Trifirò G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(1):S73-7. DOI: https://doi.org/10.4103/0976-500X.120957
Steyn H. Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017. S Afr Med J. 2023;113(6):26-33. DOI: https://doi.org/10.7196/SAMJ.2023.v113i5.16522
Valder B, Neelamma P, Nalini GK, Sahana GN. A study to assess, monitor, and reporting of adverse drug reactions in a tertiary care teaching hospital: HIMS, Hassan. Asian J Pharm Clin Res. 2023;16(7);201-3. DOI: https://doi.org/10.22159/ajpcr.2023.v16i7.46654
Alenzi KA, Alanazi NS, Almalki M, Alomrani H, Alatawi FO. The evaluation of adverse drug reactions in Saudi Arabia: A retrospective observational study. Saudi Pharm J. 2022;30(6):735-41. DOI: https://doi.org/10.1016/j.jsps.2022.03.018
Khan Z, Khan ZH, Khan Z, Karataş Y, Karataş Y, Kıroğlu O, et al. Evaluation of Adverse Drug Reactions in Paediatric Patients: A Retrospective Study in Turkish Hospital. Front Pharmacol. 2021;12:786182. DOI: https://doi.org/10.3389/fphar.2021.786182
Aagaard L, Strandell J, Melskens L, Petersen PSG, Hansen EH. Global Patterns of Adverse Drug Reactions Over a Decade: Analyses of Spontaneous Reports to VigiBaseTM. Drug Saf. 2012;35(12):1171-82. DOI: https://doi.org/10.1007/BF03262002
Ozcan G, Aykac E, Kasap Y, Nemutlu NT, Sen E, Aydinkarahaliloglu ND. Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation. Drugs - Real World Outcomes. 2016;3(1):33-43. DOI: https://doi.org/10.1007/s40801-015-0054-1
Jiang H, Lin Y, Ren W, Fang Z, Liu Y, Tan X, et al. Adverse drug reactions and correlations with drug–drug interactions: A retrospective study of reports from 2011 to 2020. Front Pharmacol. 2022;13:923939. DOI: https://doi.org/10.3389/fphar.2022.923939
Gangisetty S, Nadendla S, Goka P, Zahedabano, Prasanthi N, Rao N, et al. An Observational Prospective Study on Prevalence and Monitoring of Adverse Drug Reactions in Tertiary Care Teaching Hospital. Br J Pharm Res. 2016;11(2):1-9. DOI: https://doi.org/10.9734/BJPR/2016/24288
MedDRA®. Data Retrieval and Presentation: Points to Consider. Available at: https://alt.meddra.org/files _acrobat/001007_datretptc_r3_24_mar2024.pdf. Accessed on 12 November 2024.
Teketel Alemu Ersulo, Teketel Alemu Ersulo, Mengist Awoke Yizengaw, Awoke M, Behailu Terefe Tesfaye, Tesfaye BT. Incidence of adverse drug events in patients hospitalized in the medical wards of a teaching referral hospital in Ethiopia: a prospective observational study. BMC Clin Pharmacol. 2022 May 17;23(1). DOI: https://doi.org/10.1186/s40360-022-00570-w
Singh P, Agrawal M, Hishikar R, Joshi U, Maheshwari B, Halwai A. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year. Indian J Pharmacol. 2017;49(6):432. DOI: https://doi.org/10.4103/ijp.IJP_781_16
Dilip C, Lisa MM, Divya R. Adverse drug reaction monitoring in a tertiary level referral hospital, Kerala. Indian J Pharm Pract. 2012;5(2):28-32.
Downloads
Published
How to Cite
Issue
Section
